RegentAtlantic Capital’s Abbott ABT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $8.17M | Sell |
84,462
-7,132
| -8% | -$760K | 0.24% | 71 |
|
|
2022
Q2 | $9.95M | Buy |
91,594
+131
| +0.1% | +$14.9K | 0.33% | 56 |
|
|
2022
Q1 | $10.8M | Buy |
91,463
+1,241
| +1% | +$154K | 0.31% | 59 |
|
|
2021
Q4 | $12.7M | Buy |
90,222
+1,582
| +2% | +$202K | 0.35% | 48 |
|
|
2021
Q3 | $10.5M | Buy |
88,640
+7,654
| +9% | +$940K | 0.32% | 53 |
|
|
2021
Q2 | $9.39M | Buy |
80,986
+3,652
| +5% | +$426K | 0.29% | 58 |
|
|
2021
Q1 | $9.27M | Buy |
77,334
+14,191
| +22% | +$1.68M | 0.31% | 58 |
|
|
2020
Q4 | $6.91M | Buy |
63,143
+7,455
| +13% | +$810K | 0.27% | 72 |
|
|
2020
Q3 | $6.06M | Buy |
55,688
+4,118
| +8% | +$418K | 0.27% | 72 |
|
|
2020
Q2 | $4.71M | Buy |
51,570
+7,285
| +16% | +$658K | 0.26% | 80 |
|
|
2020
Q1 | $3.5M | Sell |
44,285
-35,082
| -44% | -$2.93M | 0.27% | 87 |
|
|
2019
Q4 | $6.89M | Sell |
79,367
-498
| -0.6% | -$41.7K | 0.42% | 64 |
|
|
2019
Q3 | $6.68M | Sell |
79,865
-610
| -0.8% | -$51.8K | 0.44% | 60 |
|
|
2019
Q2 | $6.77M | Buy |
80,475
+1,474
| +2% | +$116K | 0.46% | 58 |
|
|
2019
Q1 | $6.32M | Buy |
79,001
+4,454
| +6% | +$331K | 0.44% | 63 |
|
|
2018
Q4 | $5.39M | Buy |
74,547
+34,071
| +84% | +$2.39M | 0.46% | 65 |
|
|
2018
Q3 | $2.97M | Buy |
40,476
+975
| +2% | +$64K | 0.23% | 114 |
|
|
2018
Q2 | $2.41M | Sell |
39,501
-511
| -1% | -$31K | 0.21% | 121 |
|
|
2018
Q1 | $2.4M | Sell |
40,012
-1,031
| -3% | -$62.1K | 0.2% | 129 |
|
|
2017
Q4 | $2.34M | Sell |
41,043
-583
| -1% | -$32.3K | 0.19% | 128 |
|
|
2017
Q3 | $2.22M | Sell |
41,626
-2,081
| -5% | -$104K | 0.19% | 133 |
|
|
2017
Q2 | $2.13M | Sell |
43,707
-2,593
| -6% | -$117K | 0.19% | 134 |
|
|
2017
Q1 | $2.06M | Buy |
46,300
+9,845
| +27% | +$426K | 0.19% | 136 |
|
|
2016
Q4 | $1.4M | Sell |
36,455
-16,608
| -31% | -$659K | 0.14% | 162 |
|
|
2016
Q3 | $2.24M | Sell |
53,063
-5,506
| -9% | -$236K | 0.23% | 114 |
|
|
2016
Q2 | $2.3M | Sell |
58,569
-17,759
| -23% | -$707K | 0.22% | 111 |
|
|
2016
Q1 | $3.19M | Sell |
76,328
-14,737
| -16% | -$584K | 0.35% | 74 |
|
|
2015
Q4 | $4.09M | Sell |
91,065
-9,719
| -10% | -$429K | 0.44% | 63 |
|
|
2015
Q3 | $4.05M | Sell |
100,784
-2,155
| -2% | -$102K | 0.39% | 68 |
|
|
2015
Q2 | $5.05M | Sell |
102,939
-8,783
| -8% | -$422K | 0.45% | 59 |
|
|
2015
Q1 | $5.18M | Sell |
111,722
-8,565
| -7% | -$393K | 0.45% | 56 |
|
|
2014
Q4 | $5.42M | Sell |
120,287
-11,305
| -9% | -$492K | 0.46% | 54 |
|
|
2014
Q3 | $5.47M | Sell |
131,592
-6,312
| -5% | -$267K | 0.51% | 51 |
|
|
2014
Q2 | $5.64M | Sell |
137,904
-1,648
| -1% | -$64.7K | 0.53% | 50 |
|
|
2014
Q1 | $5.37M | Sell |
139,552
-759
| -0.5% | -$29.3K | 0.52% | 50 |
|
|
2013
Q4 | $5.38M | Buy |
140,311
+9,278
| +7% | +$342K | 0.52% | 49 |
|
|
2013
Q3 | $4.35M | Buy |
131,033
+17,546
| +15% | +$616K | 0.47% | 53 |
|
|
2013
Q2 | $3.96M | Buy |
+113,487
| New | +$4.16M | 0.47% | 57 |
|
Other funds holding ABT
RegentAtlantic Capital's ABT Position: Q3 2022 in Review
RegentAtlantic Capital reduced its Abbott (ABT) stake by 7.8% in Q3 2022, selling an estimated $760K and leaving 84,462 shares worth $8.17M. The position accounts for 0.24% of the portfolio, ranked #71.
RegentAtlantic Capital first reported a position in ABT in Q2 2013 and has held it in 38 quarters since. The position peaked at $12.7M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold ABT as of Q3 2022.
- RegentAtlantic Capital held 84,462 shares of Abbott worth $8.17M as of Q3 2022.
- RegentAtlantic Capital sold 7,132 Abbott shares in Q3 2022, an estimated $760K.
- Abbott made up 0.24% of RegentAtlantic Capital's portfolio in Q3 2022, its #71 holding.
- RegentAtlantic Capital first reported a position in Abbott in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Abbott position peaked at $12.7M in Q4 2021.
- 2,620 funds tracked by Wall St. Rank held Abbott as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.